December 19, 2018: A contract signed with SLU for a continued research grant for 2019.

December 12, 2018: Private placements of 13.5 MSEK.

September 11, 2018: The grant of the ULT2 patent in Sweden was published.

August 28, 2018: Swedish patent application (ULT3) submitted concerning cyclic peptides.

May 24, 2018: Continuation in part (ULT2) submitted in USA concerning new methods of treating bacterial infections.

May 24 - June 1, 2018: National patent applications (ULT1) submitted in USA, Japan, Australia, Canada, China and Europe, concerning new compounds for treating bacterial infections.

May 10 - June 19, 2018: National patent applications (ULT2) submitted in USA, Japan, Australia, Canada, China and Europe, concerning new methods of treating bacterial infections.

April 16, 2018: Divisional Patent Application to ULT2 filed in Sweden.

April 13, 2018: Annual General Meeting.

November 13, 2017: Ultupharma joined Beam Alliance.

October 30, 2017: A publication in Journal of Natural Products, 2017, 80, 2997-3002: Antibacterial 3,6-Disubstituted 4-Hydroxy-5,6-dihydro-2H-pyran-2-ones from Serratia plymuthica MF371-2
Authors: Joakim Bjerketorp, Jolanta J. Levenfors, Christer Sahlberg, Christina L. Nord, Pierre F. Andersson, Bengt Guss, Bo Öberg and Anders Broberg

October 3, 2017: The grant of the ULT1 patent in Sweden was published.

September 26, 2017: A contract signed with SLU for a continued research grant for q3 and q4 of 2018.

August 3, 2017: PCT application (ULT2) concerning new compunds and methods of treating bacterial infections published as WO 2017/131576, available e.g. from http://www.epo.org

June 27, 2017: A publication in Molecules 2017, 22 (7), 1072. Labradorins with Antibacterial Activity Produced by Pseudomonas sp. Authors: Anders Broberg, Joakim Bjerketorp, Pierre Andersson, Christer Sahlberg and Jolanta J. Levenfors.

June 8, 2017: PCT application (ULT1) concerning new compunds and methods of treating bacterial infections published as WO 2017/095319, available e.g. from http://www.epo.org

February 25, 2017: Private placements of 15 milj SEK.

January 27, 2017: PCT application (ULT2) submitted concerning new methods of treating bacterial infections.

January 27, 2017: A contract signed with the Swedish University of Agricultural Sciences (SLU) for a research grant for the next 18 months for studies of antibiotic effects of secondary metabolites in fungi and bacteria.

December 2, 2016: PCT application (ULT1) submitted concerning new compounds for treating bacterial infections.